Background -Gastric cancer is the second leading cause of cancer-related death globally. Unfortunately, the survival rate of the gastric cancer patients who underwent chemotherapy following surgery has been less than a half. Besides, chemotherapy has many side effects. Current evidence suggests that some antidepressants like duloxetine have growth-inhibiting effects against a number of cancer cell lines. Objective -Thus, the aim of this study was to determine the cytotoxic and genotoxic effects of duloxetine on gastric cancer. Methods -In this regard, the cytotoxicity and genotoxicity of duloxetine were investigated in MKN45 and NIH3T3 cell lines by MTT assay and on peripheral blood lymphocytes by MN assay. For this purpose, cells were cultured in 96 wells plate. Stock solutions of duloxetine and cisplatin were prepared. After cell incubation with different concentrations of duloxetine (1, 10, 25, 50, 100 and 200 μL), MTT solution was added. For micronucleus assay fresh blood was added to RPMI culture medium 1640 supplemented, and different concentrations of duloxetine (1, 10, 25, 50, 100 and 200 μL) were added. Results -The cytotoxicity of duloxetine on MKN45 cancer cell line and NIH3T3 normal cell line were studied followed by MTT assay. duloxetine exhibited higher IC 50 in the MKN45 cells in comparison with the NIH3T3 cells. In addition, genotoxic effect of duloxetine was evaluated by micronucleus assay. The results revealed that duloxetine induced more DNA damage at 100 and 200 μM and no significant difference at 200 μM with respect to cisplatin, but it had less genotoxic effects at 100 and 50 μM concentrations. Conclusion -Although, in this study, duloxetine had less genotoxicity than cisplatin in concentrations under 200 μM and showed cytotoxic effects as well, due to its IC 50 , it cannot be considered as a better choice for gastric cancer therapies with respect to cisplatin as a common anticancer drug.
INTRODUCTION
Gastric cancer is believed to be the fourth most common type of cancer; it is also the second leading cause of cancer-related death globally. Unfortunately, the survival rate of the gastric cancer patients who underwent chemotherapy following surgery has remarkably been less than a half (1) . Furthermore, chemotherapy has many side effects (2) . Current evidence suggests that some antidepressants have growth-inhibiting effects against a number of cancer cell lines and they are now reported to have potent anti-cancer properties against a wide variety of malignancies in addition to their antipsychotic effects (3, 4) . Today, duloxetine is a widely used antidepressant worldwide with the advent of drug therapy and the emergence of new antidepressant drugs by the various recent research (5, 6) . The neuronal reuptake of serotonin 5-Hydroxytryptamine, 5-HT) and norepinephrine are usually inhibited by duloxetine ((+) -(S) -N-Methyl-γ-(1-naphthyloxy) -2-thiophenylpropylamine), so in order to manage diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain, duloxetine is prescribed in the United States (7) . While, it is noticeable that in recent years, duloxetine has shown dose-dependent cytotoxicity on some cancer cell lines such as MCF-7 and HepG2 and it was suggested that this agent should be further evaluated for potential use (3, 8, 9) . MTT assay is one of the most widely used methods for cytotoxicity screening (10) . On the other hand, due to the limited data on the genotoxicity of drugs, the number of drugs that can actually be safely used has been decreased. Thus, in vitro genotoxicity tests are used to detect materials that damage genetic material and lead to DNA break, mutations, chromosomal breaks, or impaired ability to repair DNA, which is an important indicator of carcinogenesis (9, (11) (12) (13) . One of the genotoxic assays which is widely applicable in different cell types, is internationally validated, has potential for automation and is predictive for cancer is micronucleus(MN) assay (14, 15) . Due to the fact that common anticancer drugs such as cisplatin, doxorubicin, docetaxel, and etc. have many side effects, it is now highly desirable to build and use new drugs that have less toxicity to normal cells and high toxicity to malignant cells (2, (16) (17) (18) (19) . The anticancer effects of duloxetine on some cancer cell lines have been investigated, but in gastric cancer MKN45 cancer cell line has not yet been studied (20) (21) (22) (23) (24) (25) . Therefore, the purpose of this study is to examine the effects of duloxetine on metastatic cells. In this regard, its cytotoxicity and genotoxicity was investigated in MKN45 and NIH3T3 cell lines and on peripheral blood lymphocytes.
METHODS

Cell culture
NIH3T3 and MKN45 Cell lines (Pasteur Institute, Tehran, Iran) were cultured in Dulbecco's Modified Eagle Medium (DMEM) (GIBCO, Berlin, Germany) with 10% fetal bovine serum (FBS) (Gibco-BRL, Germany) and 100 μg/mL streptomycin (Gibco-BRL, Germany) and 100 IU/mL penicillin (Gibco-BRL, Germany). Cell cultures were adjusted to allow for exponential growth.
Cell viability assay (MTT assay)
NIH3T3 and MKN45 cell lines (10 4 cells) were cultured in 200 μL DMEM/F12 medium containing 10% bovine serum in 96 wells plate and incubated at 37°C for 24h. Stock solutions of duloxetine and cisplatin (a platinum coordination complex with potent anti-neoplastic activity induces apoptosis in cancer cells, possibly via caspase-3 activation) were prepared in 1% DMSO and phosphate buffered saline (PBS), respectively. Twenty-μL of MTT solution (5 mg/mL) was added to each well following 48h incubation with different concentrations of duloxetine (1, 10, 25, 50, 100 and 200 μL). The optical density (OD) of the MTT reaction was measured on a microplate ELISA reader at 570 nm. All experiments were repeated two times and each treatment was run in triplicate. The percentage of cell viability was calculated using the equation: [mean (OD) of treated cells/mean OD of control cells (1%DMSO)] ×100 (26) .
Micronucleus assay
Fresh blood was collected from 10 healthy, no smoking, no alcoholic, male donors aged between 25-35 years by venipuncture in heparinized falcons. 0.5 mL of whole blood was added to 4.5 mL of Roswell Park Memorial Institute (RPMI) culture medium 1640 supplemented with 10% fetal bovine serum containing L-glutamine, antibiotics, and phytohemagglutinin (PHA), and different doses of duloxetine (1, 10, 25, 50, 100 and 200 μL). The binucleated lymphocytes were harvested 28h after adding Cytochalasin B (Cyt-B) (Sigma, Missouri, USA); they were treated by hypotonic KCl (0.075M) to red blood cell (RBC) lysis. Then fixative solution (methanol: acetic acid =6:1) was added to the cells prior to slide preparation and staining. For slide preparation, 2-3 drops of cell suspension were thrown on a clean slide. The slides were stained with Giemsa solution (4%) for 7-10 mins. They were observed at 40× and 100× magnifications using a light microscope to estimate mitotic index (the cells with 2 or more nuclei per 1000 observed cells) and micronuclei frequency (the number of micronuclei in 1000 binucleated cells) are lymphocytes that were once divided by mitosis. The experiment was performed two times. Mitotic Index has a direct relation with cells' proliferative activity (27) .
Statistical analysis
One way analysis of variance and Tukey's honestly significant differences (HSD) test were used for multiple comparisons of data. P value less than 0.05 was considered as significant. The IC 50 (half maximal inhibitory concentration) values were calculated by PRISM software using nonlinear regression. Standard deviations represent average results of double experiments. The IC 50 values were compared using the Student's t-test measuring the effectiveness of a substance to cause cell death or inhibit cell growth. Therefore, the lower amount of IC 50 represents a higher toxicity of a compound, which leads to death or inhibition of cell growth.
RESULTS
MTT assay
The IC 50 of duloxetine on MKN45 and NIH3T3 cell lines were examined using MTT assay. The IC 50 of duloxetine on MKN45 cancer cell line was 40.41 μg/mL and on NIH3T3 cell line was 15.79 μg/mL, which implies that the IC 50 of duloxetine related to the NIH3T3 cell line was lower than the MKN45 cell line. The evaluated IC 50 of cisplatin on MKN45 cell line was 12.49 μg/mL and on NIH3T3 cell line was 24.9 μg/mL. A lower IC 50 value is representative of the higher ability of a cytotoxic compound to cause cell death or inhibit cell growth (28) . It means that the inhibitory effect of growth and the most cytotoxicity of the drug are on the normal cell line in comparison with the cancer cell line. The results of the MKN45 cell line ( FIGURE 2 ) showed that duloxetine in comparison with the negative control group was significantly different in all concentrations; it means that it had more cytotoxic effects in every data. Moreover, in comparison with the positive control group, it had less cytotoxic effects at 1, 10, 25, 50 μM and no significant difference at 100 and 200 μM concentrations (P<0.05).
caused by this drug was also evaluated using MN assay. The IC 50 of duloxetine on MKN45 cancer cell line and NIH3T3 cell line was calculated 40.41 μg/mL and 15.79 μg/mL respectively. However, the IC 50 of cisplatin on MKN45 is 12.49 μg/mL and on NIH3T3 cell line is 24.9 μg/mL. The lower IC 50 value is representative of the higher ability of a cytotoxic compound to cause cell death or inhibit cell growth. As reported here, the dose-dependent cytotoxicity of duloxetine on MKN45 cancer cell line is consistent with some other researches (3, 8) . The cytotoxic effects of the seven most commonly prescribed antidepressants was evaluated on MCF-7 breast cancer cell line (13, 29) . Their results showed that Sertraline was the most potent drug in growth inhibition and had to be further analyzed (3) . The anti-tumor effects of four SSRIs and two SNRIs on HepG2 cells were compared as well, and the IC 50 reduced relatively in the order of sertraline, paroxetine, duloxetine, fluvoxamine, escitalopram, and milnacipran (8, 30) . Besides, the anti-viability effects of some drugs were fully proved on the proliferation of MKN45 cell line (20) (21) (22) (23) (24) . Nonetheless, by comparing the cytotoxic effects and the IC 50 of duloxetine on MKN45 and NIH3T3 cell lines it was shown that the cytotoxic effects of duloxetine on NIH3T3 normal cell line was higher than MKN45 cancer cell line. Taken together, it seems that duloxetine in the concentrations presented in this research could not be considered as a better choice for MKN45 gastric cancer therapy. Additionally, we used lymphocytes in our in vitro studies to assess the potential genotoxic effect of duloxetine. Results from the micronucleus assay confirmed the ability of duloxetine to induce the formation of micronuclei. The induction of micronuclei is commonly used to evaluate the chromosomal damage. The cellular and tissue 
Micronucleus assay
The genotoxic effects of duloxetine were studied based on the number of MN produced in peripheral blood lymphocytes following treatment with different concentrations of duloxetine (TABLE 2 and FIGURE 3 ). Results showed that the MN number was relatively increased based on the increase in the duloxetine concentration. Fifty-μM concentration of duloxetine did not produce any significant difference in MN number relative to the control group. While, 100 and 200 μM concentrations of duloxetine significantly increased the number of MN. Comparison of different concentrations of duloxetine and cisplatin showed that treatment of lymphocytes with 50 and 100 μM of duloxetine significantly decreased the number of MN. Two hundred-μM concentration of duloxetine did not produce any significant difference in MN number relative to the cisplatin (P<0.05).
DISCUSSION
In this study, the cytotoxic effect of duloxetine on MKN45 gastric cancer cell line was investigated and compared to NIH3T3 normal cell line by MTT assay. The NIH3T3 cell line used in this study is the murine embryonic fibroblast, which is a standard and reliable source for these studies. Moreover, the genetic damage TABLE2. Micronuclei frequency in different concentrations of duloxetine.
Control Duloxetine 50 Duloxetine 100 Duloxetine 200 Cisplatin
Mean ± SD 0.6667±0.5774 4.667±2.082 11.00±1.000 16.67±2.082 17.67±3.055 toxicity was observed in the increased therapeutic concentrations of duloxetine. duloxetine and its metabolites can bind DNA, causing damage that can result in chromosome breaks, micronucleus formation, and cell death. As evident, duloxetine induced DNA damage to human lymphocytes compared to the negative control group except at 50 μM concentration. In addition, this drug had no significant difference with cisplatin at 200 μM concentration, but it had a low genotoxicity at 100 and 50 μM concentrations (P<0.05). It confirmed that this drug is safe to be used at these concentrations. A recent report in mouse bone marrow was made to evaluate the capacity of three doses of duloxetine (2, 20, and 200 mg/kg). Their results indicated a moderate but significant increase of SCE (sister chromatid exchanges) with three concentrations tested, no effect regarding the mitotic index and a small reduction in the proliferation kinetics (5, 31) . Also the possible genotoxic potential of duloxetine was explored by evaluating structural chromosomal aberrations, mitotic index, nuclear division index, index binucleation, number of cells (with one, two, three and four micronuclei) and the number of cells with nucleoplasmic bridges. As the positive control, Cyclophosphamide (6 μg/mL) and different concentrations of duloxetine (10-150 ng/mL) were applied on primary cultures of blood lymphocytes. Their results showed that the cultures incubated with duloxetine indices had lower scores suggesting a degree of the drug cytotoxicity. However, a significant increase in the presence of chromosomal aberrations and micronuclei was observed only by the concentrations of 100 and 150 ng/mL. It should be noted these concentrations were close to the upper limit of the therapeutic range of the drug used in humans (Araújo, 2014) . Our genotoxic studies were in line with the past studies earlier mentioned.
CONCLUSION
In conclusion, given that, this is the first time that cytogenetic study of duloxetine was evaluated and compared in MKN45 and NIH3T3 cell lines, based on the results of this study and comparisons with cisplatin in these concentrations, its value is low.
Because the higher IC 50 shows less power of sample in killing cells or inhibiting their growth. In addition, the genetic damage caused by duloxetine in blood lymphocytes had no significant difference with cisplatin at higher concentrations. Hassani 
